Massivemarkets

SEC Form 4

Covista Inc. (CVSA) insider trading

In the 12 months to Oct 26, 2026, 5 CVSA insiders reported open-market sales of $10.3M across 13 filings; one director bought $3.8M.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$10.3M
13 filings · 5 insiders
Open-market purchases
$3.8M
2 filings · Michael W. Malafronte, Director
Pre-arranged sales (10b5-1)
13 of 13
All $10.3M sold was pre-arranged

Who traded CVSA, and when

  • Purchase
  • Sale
  • Sale, pre-arranged (10b5-1)

CVSA daily close from Feb 24, 2026 to Oct 26, 2026, between $96.07 and $140.98, last $131.32. 13 sale and 2 purchase filings by 6 insiders, marked at their filing dates. Stephen W. Beard, Chairman & CEO: sold $5.0M across 5 filings, first filed May 12, 2026, last Oct 9, 2026. Michael W. Malafronte, Director: bought $3.8M across 2 filings, first filed Mar 5, 2026, last Mar 12, 2026. Douglas G. Beck, SVP, GC, Corp. Sec & ISS: sold $2.5M across 3 filings, first filed May 12, 2026, last Aug 11, 2026. Robert J. Phelan, Chief Financial Officer: sold $2.3M across 3 filings, first filed May 12, 2026, last Aug 11, 2026. Karen Sue Cox, President, Chamberlain Univ.: sold $249.0K across 1 filing, first filed May 12, 2026, last May 12, 2026. Manjunath Gangadharan, VP, Chief Accounting Officer: sold $247.2K across 1 filing, first filed Aug 28, 2026, last Aug 28, 2026.

Largest mark · tap a row for others

Michael W. Malafronte · Director

Purchase $3,635,414

36,036 shares at $100.88 avg

Filed Mar 12, 2026 · traded Mar 10

Close on filing date $103.84

CVSA daily closelast $131.32

Stephen W. Beard · Chairman & CEO

$5.0M sold

Michael W. Malafronte · Director

$3.8M bought

Douglas G. Beck · SVP, GC, Corp. Sec & ISS

$2.5M sold

Robert J. Phelan · Chief Financial Officer

$2.3M sold

Karen Sue Cox · President, Chamberlain Univ.

$249.0K sold

Manjunath Gangadharan · VP, Chief Accounting Officer

$247.2K sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

15 filings in the last 12 months
Other insider activity (not market trades) · 32 records
  • Tax withholding18 records
  • Grants and awards13 records
  • Gifts1 record

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

Frequently asked questions

Has Covista Inc.'s CEO sold stock?

Yes. Stephen W. Beard (CEO) sold 38,307 shares ($5.0M) between May 2026 and Oct 2026, all under a pre-arranged 10b5-1 plan.

How current is CVSA’s insider data?

These are CVSA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track CVSA insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CVSA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.